Options for recanalization therapy in basilar artery occlusion.
Lindsberg
Perttu J
PJ
Department of Neurology, Helsinki University Central Hospital, Finland. perttu.lindsberg@hus.fi
Soinne
Lauri
L
Roine
Risto O
RO
Tatlisumak
Turgut
T
D001157:Arterial Occlusive Diseases / Q000628:therapy*; D001488:Basilar Artery / Q000473:pathology*; D015331:Cohort Studies; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D011379:Prognosis; D012306:Risk; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use; D016896:Treatment Outcome; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator